Tesaro Shakes Up EU PARP Market With Zejula Launches
EU approval signals the start of a marketing push against the combined might of AstraZeneca and Merck & Co – Tesaro believes it has the label to set it apart. For now, at least.

EU approval signals the start of a marketing push against the combined might of AstraZeneca and Merck & Co – Tesaro believes it has the label to set it apart. For now, at least.